News

September 2, 2009 – Abbott announced Monday at the European Society of Cardiology Congress the widespread availability of its next-generation XIENCE PRIME Everolimus-Eluting Coronary Stent System for the treatment of coronary artery disease.

Home September 02, 2009
Home
News

September 2, 2009 – Volcano Corp. said this week it entered into a nonexclusive, global resale agreement with Siemens Healthcare where Siemens will resell Volcano’s s5i IVUS/FFR systems and accessories alongside Siemens' Artis family of X-ray systems.

Home September 02, 2009
Home
Technology

September 2, 2009 – A new analysis from the JUPITER study showed CRESTOR (rosuvastatin calcium) 20 mg reduced the composite primary end point of major cardiovascular (CV) events (myocardial infarction, stroke, arterial revascularization, hospitalization for unstable angina, or death from CV causes) by 39 percent, compared to placebo, in elderly patients with LDL-C less than 130 mg/dL and elevat

Home September 02, 2009
Home
News

September 1, 2009 - Evaluation of results of a multicenter study indicates that quantitative evaluation of the progression of volume of extracranial carotid vessel walls is feasible with 1.5T magnetic resonance (MR) imaging, despite limitations due to patient motion or habitus.

Home September 01, 2009
Home
News

September 1, 2009 – Cordis Corp. said first patient has been enrolled in the CYPRESS study, which will assess clinical outcomes in a broad range of patients with coronary artery disease who take dual anti-platelet therapy after receiving a CYPHER sirolimus-eluting coronary stent. The procedure was performed by Patrick Flaherty, D.O., Arkansas Heart Hospital in Little Rock, Ark.

Home September 01, 2009
Home
News

September 1, 2009 – St. Jude Medical Inc. today announced European launch of the next generation version 4.0 of its Merlin.net Patient Care Network (PCN), a secure, Internet-based remote care system for patients with implanted medical devices.

Home September 01, 2009
Home
News

September 1, 2009 – Sanofi-aventis said Sunday the investigational anti-Xa intravenous anti-coagulant otamixaban reduced by 27 to 42 percent the odds of the composite primary endpoint of death, myocardial infarction, urgent revascularization or rescue GPIIb/IIIa use in four out of the five otamixaban tested doses, versus standard UFH/eptifibatide combination in (non-ST) ACS patients suitable for

Home September 01, 2009
Home
News

September 1, 2009 - BioClinica Inc., a clinical trial services provider, today announced that it has acquired the CardioNow unit of Agfa HealthCare to offer streamlined electronic transport solutions to facilitate the blinding, sharing, tracking and archiving of medical images for multi-center clinical trials as part of its suite of imaging services.

Home September 01, 2009
Home
Feature

September 1, 2009 – AstraZeneca last week announced results from the phase III head to head trial, PLATO (A Study of Platelet Inhibition and Patient Outcomes), which demonstrate that ticagrelor (BRILINTA) has achieved greater efficacy in the primary endpoint, reduction of cardiovascular events (CV death, MI, stroke) over clopidogrel (Plavix/Iscover ) (9.8 vs.

Home September 01, 2009
Home
News

September 1, 2009 – Toshiba America Medical Systems Inc. will demonstrate its Next Generation Advanced Image Processing (AIP) feature, available on the Infinix-i product line at this year’s Transcatheter Cardiovascular Therapeutics Annual Scientific Symposium.

Home September 01, 2009
Home
News

September 1, 2009 – Echocardiography with Doppler is the method of choice for the noninvasive evaluation of prosthetic valves, according to a new guideline document in the September issue of the Journal of the American Society of Echocardiography (JASE).

Home September 01, 2009
Home
News

September 1, 2009 – CardioDx said last week it successfully completed its multicenter validation study for Corus CAD, the first gene expression test to quantify the likelihood of obstructive(1) coronary artery disease (CAD) in patients with stable chest pain.

Home August 31, 2009
Home
News

September 1, 2009 – GE Healthcare and 2D/3D/4D imaging company TomTec Imaging Systems GmbH entered into a formal strategic cooperation contract to boost their excellence in echocardiography.

Home August 31, 2009
Home
News

August 31, 2009 – IDEV Technologies Inc. announced last week the first patient was enrolled in the company's FDA-approved multicenter clinical trial of its self-expanding SUPERA stent for the treatment of biliary and peripheral artery disease (PAD) in the superficial femoral artery (SFA).

Home August 31, 2009
Home
News

August 26, 2009 – Siemens Healthcare is now shipping its syngo US Workplace 3.5, with ultrasound applications for clinical workflow and patient care for cardiac imaging, general imaging, OB/GYN and vascular screening, including the syngo Arterial Health Package (AHP) for semi-automated carotid intima-media thickness (CIMT) measurements.

Home August 26, 2009
Home
Subscribe Now